Products
products details
Home > Products >
β-Amyloid (25-35) (human) Alzheimer's Peptide Catalog KS011006 CAS 131602-53-4

β-Amyloid (25-35) (human) Alzheimer's Peptide Catalog KS011006 CAS 131602-53-4

Product Details:
Catalog Number:
KS011006
Product Name:
β-Amyloid (25-35) (human)
Sequence:
GSNKGAIIGLM
CAS NO.:
131602-53-4
Price/1mg:
$66
Purity:
≥95% (HPLC)
Molecular Formula:
C59H102N16O21S
Molecular Weight:
1403.6
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
High Light: 

Beta Amyloid Alzheimer's Peptide

,

Β-Amyloid Alzheimer's Peptide

,

Human β amyloid peptide

Product Description

β-Amyloid (25-35) (human),Catalog Number: KS011006,CAS NO.:131602-53-4

 

Amyloid fragment shown to produce both the neurotoxic and the neurotrophic effects of beta-amyloid protein on cultured neurons. Furthermore, the peptide forms aggregates and typical amyloid fibrils resembling those of the beta-amyloid protein in senile plaque cores.

 

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australia,Asia,Middle East,Africa

 

Products
products details
Home > Products >
β-Amyloid (25-35) (human) Alzheimer's Peptide Catalog KS011006 CAS 131602-53-4

β-Amyloid (25-35) (human) Alzheimer's Peptide Catalog KS011006 CAS 131602-53-4

Product Details:
Catalog Number:
KS011006
Product Name:
β-Amyloid (25-35) (human)
Sequence:
GSNKGAIIGLM
CAS NO.:
131602-53-4
Price/1mg:
$66
Purity:
≥95% (HPLC)
Molecular Formula:
C59H102N16O21S
Molecular Weight:
1403.6
Form:
Lyophilized
Storage:
Store At -20°C Or -80°C
Details Link:
Https://shopping.ks-vpeptide.com/sale-470429-amyloid-25-35-human-alzheimer-s-peptide-catalog-ks011006-cas-131602-53-4.htm
High Light: 

Beta Amyloid Alzheimer's Peptide

,

Β-Amyloid Alzheimer's Peptide

,

Human β amyloid peptide

Product Description

β-Amyloid (25-35) (human),Catalog Number: KS011006,CAS NO.:131602-53-4

 

Amyloid fragment shown to produce both the neurotoxic and the neurotrophic effects of beta-amyloid protein on cultured neurons. Furthermore, the peptide forms aggregates and typical amyloid fibrils resembling those of the beta-amyloid protein in senile plaque cores.

 

Main Sales Markets: North America,Central/South America,Western Europe,Eastern Europe,Australia,Asia,Middle East,Africa